Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Criscitiello, Carmen"'
Autor:
Mariani M; Università Vita-Salute San Raffaele, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Viale G; Università Vita-Salute San Raffaele, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Galbardi B; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Licata L; Università Vita-Salute San Raffaele, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Bosi C; Università Vita-Salute San Raffaele, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Dugo M; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Notini G; Università Vita-Salute San Raffaele, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Naldini MM; Università Vita-Salute San Raffaele, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy., Callari M; Fondazione Michelangelo, Milan, Italy., Criscitiello C; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milano, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy., Pusztai L; Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, Connecticut., Bianchini G; Università Vita-Salute San Raffaele, Milan, Italy.; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Jul 01; Vol. 7 (7), pp. e2423390. Date of Electronic Publication: 2024 Jul 01.
Autor:
Esposito A; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy., Marra A; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy., Bagnardi V; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy., Frassoni S; Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy., Morganti S; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy., Viale G; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy., Zagami P; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy., Varano GM; Division of Interventional Radiology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Buccimazza G; Division of Interventional Radiology, IEO, European Institute of Oncology IRCCS, Milan, Italy; University of Milano, Milan, Italy., Orsi F; Division of Interventional Radiology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Venetis K; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Mazzarella L; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Experimental Oncology, IEO, European Institute of Oncology IRCSS, Milan, Italy., Viale G; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Fusco N; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Criscitiello C; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy., Curigliano G; Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milano, Milan, Italy. Electronic address: giuseppe.curigliano@ieo.it.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Mar; Vol. 145, pp. 197-209. Date of Electronic Publication: 2021 Jan 22.
Autor:
Criscitiello C; Division of Early Drug Development, European Institute of Oncology, Milano, Italy., Santangelo M; Department of Advanced Biomedical Science, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy., Loupakis F; Medical Oncology Unit 1, Clinical and Experimental Oncology Department, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Publikováno v:
BioMed research international [Biomed Res Int] 2018 Mar 20; Vol. 2018, pp. 5184075. Date of Electronic Publication: 2018 Mar 20 (Print Publication: 2018).
Autor:
Esposito A; Istituto Europeo di Oncologia, Division of Experimental Cancer Medicine, Via Ripamonti 435, Milan, Italy., Criscitiello C, Curigliano G
Publikováno v:
Current opinion in oncology [Curr Opin Oncol] 2015 Nov; Vol. 27 (6), pp. 445-51.
Autor:
Criscitiello C, Curigliano G
Publikováno v:
Progress in tumor research [Prog Tumor Res] 2015; Vol. 42, pp. 30-43. Date of Electronic Publication: 2015 Sep 04.
Autor:
Gelao L; Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, Milano 20141, Italy. lucia.gelao@ieo.it., Criscitiello C; Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, Milano 20141, Italy. carmen.criscitiello@ieo.it., Esposito A; Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, Milano 20141, Italy. angela.esposito@ieo.it., Goldhirsch A; Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, Milano 20141, Italy. aaron.goldhirsch@ieo.it., Curigliano G; Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Via Ripamonti 435, Milano 20141, Italy. giuseppe.curigliano@ieo.it.
Publikováno v:
Toxins [Toxins (Basel)] 2014 Mar 03; Vol. 6 (3), pp. 914-33. Date of Electronic Publication: 2014 Mar 03.
Autor:
Criscitiello C, Esposito A, Gelao L, Fumagalli L, Locatelli M, Minchella I, Adamoli L, Goldhirsch A, Curigliano G
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2014 Feb 25; Vol. 16 (1), pp. 204. Date of Electronic Publication: 2014 Feb 25.
Autor:
Criscitiello C; Division of Early Drug Development for Innovative Therapies, Istituto Europeo di Oncologia, Milan, Italy., Curigliano G
Publikováno v:
Current opinion in oncology [Curr Opin Oncol] 2013 Nov; Vol. 25 (6), pp. 602-8.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.